AlphaVax 's in-house focus is today on the commercial potential of its alphavaccine vector technology in cancer immunotherapy. External third party partners are working on anti-infective vaccines. We are a privately-held, clinical-stage biopharmaceutical company, that has used its proprietary RNA particle alphavaccine vector platform technology to generate a portfolio of seven vaccine candidates for infectious disease prevention and cancer immunotherapy. The alphavaccine technology is based on AlphaVax’s proprietary RNA.
This company is:
Keywords
Industries
City: Durham
State: North Carolina
Country: United States
Where is AlphaVax located?
The company AlphaVax is located in Durham, North Carolina, United States. It's worth noting that the company may has more corporate locations
How many employees does AlphaVax approximately have?
As of the latest available information AlphaVax has around 51-100 employees worldwide.
When was AlphaVax founded?
AlphaVax was founded in 1997
In which industries does AlphaVax mainly work?
The company AlphaVax has it's main focus in the industries of Other
What is the current company status of AlphaVax?
Based on the founding year and the amount of employees the company AlphaVax seems to be a Medium-Sized Company at the current state. Note that over time that status can change
Virovax Limited
United Kingdom
1-10 Employees
2016
View
Altevax
France
1-10 Employees
2016
View
Prime Vector Technologies
Germany
1-10 Employees
2019
View
Vaxine
Australia
11-50 Employees
2002
View
ImmVirX
Australia
11-50 Employees
2019
View
Aegis Life Inc.
United States
11-50 Employees
2020
View
XVir Therapeutics GmbH
Germany
1-10 Employees
2004
View
THERAVECTYS
France
11-50 Employees
2005
View
Topics which have been searched by others and may be interesting for you:
